Global Stem Cells GroTurkeyup subsidiary Stem Cell Training Announces First Training Course to Take Place in Turkey
Global Stem Cell Training, Inc. announces plans to conduct the first stem cells harvesting and reintegration training course in Turkey Sept. 15 and 16, 2015. The training course will be held in Istanbul and lead by world renowned plastic surgeon Tunc Tiryaki, M.D.
Global Stem Cells Group and its subsidiary Stem Cell Training, Inc. have announced plans to conduct Turkey’s first ever stem cell
Tunv Tryak, M.D.
harvesting and reintegration course Sept 15 and 16, 2015. Through his alliance with Stem Cell Training, Inc. and in conjunction with medical device manufacturer Marina Medical, Tunc Tiryaki, M.D. will conduct the Adipose and Bone Marrow Stem Cell Training Course for medical professionals in Istanbul.
Tiryaki, a renowned plastic surgeon practicing in London and Istanbul, is a pioneer in cell enriched fat transfer. The course will focus on stem cell therapies for cosmetic/aesthetic conditions.
The Adipose and Bone Marrow Stem Cell Training Course was developed for physicians and high-level practitioners to learn the process through an intensive, hands-on training session to arm participating physicians with clinical protocols and state-of-the-art techniques for isolating and re-integrating adipose- and bone marrow-derived stem cells.
The objective of the training is to bridge the gap between bench science in the laboratory and the doctor’s office by teaching effective, in-office regenerative medicine techniques.
Global Stem Cells Group’s Stem Cell Training, Inc. courses have been extended to approximately 35 countries, allowing a global community of physicians to learn how to apply these new stem cell technologies.
For more information, visit the Stem Cell Training, Inc. website, email info(at)stemcelltraining(dot)net, or call 305-560-5337.
About Global Stem Cells Group:
Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions.
With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.
Global Stem Cells Group’s corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCG’s six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.
Global Stem Cells Group is a publicly traded company operating under the symbol MSSV. https://finance.yahoo.com/quote/mssv/
About Stem Cell Training, Inc.:
Stem Cell Training, Inc. is a multi-disciplinary company offering coursework and training in 35 cities worldwide. Coursework offered focuses on minimally invasive techniques for harvesting stem cells from adipose tissue, bone marrow and platelet-rich plasma. By equipping physicians with these techniques, the goal is to enable them to return to their practices, better able to apply these techniques in patient treatments.
The company’s training courses are designed to make the best use of stem cell technology available to treat various diseases in a manner that is accessible to everyone. Stem Cell Training, Inc.’s mission is to introduce the promising world of cellular medicine to everyone who can benefit from its application, and to provide high quality, effective and efficient training that complies with the highest medical standards to physicians worldwide.
###
- Published in Press Releases
Global Stem Cells Group Announces First Stem Cell Training Course to Take Place in Romania
Stem Cell Training, Inc., a subsidiary of Global Stem Cells Group, announces plans to conduct the first stem cell training course in Romania Nov. 27-28, 2015. The training class will be held in Bucharest and lead by Cosmetic Surgeon Morad Iancu, M.D.
Global Stem Cells Group and its subsidiary Stem Cell Training, Inc. have announced plans to conduct Romania’s first ever stem cells harvesting and reintegration course Nov. 27-28, 2015. Through an alliance with Miami-based Stem Cell Training, Inc., Cosmetic Surgeon Morad Iancu, M.D. will conduct the Adipose and Bone Marrow Stem Cell Training Course for medical professionals in Bucharest.
Iancu is a reconstructive plastic surgery specialist practicing in Bucharest and Tel Aviv, Israel, and a popular “celebrity doctor” in Eastern Europe.
The Adipose and Bone Marrow Stem Cell Training Course was developed for physicians and high-level practitioners to learn the process of isolating and re-integrating adipose- and bone marrow-derived stem cells through an intensive, hands-on training session. The objective is to arm participating physicians with clinical protocols and state-of-the-art regenerative medicine techniques so that they can bring regenerative medicine therapies to their patients in-office. Iancu will focus the training session on stem cell treatments in cosmetic applications.
Global Stem Cells Group’s Stem Cell Training, Inc. courses have been extended to approximately 35 countries, allowing a global community of physicians to learn how to apply these new stem cell technologies.
For more information, visit the Stem Cell Training, Inc. website, email info(at)stemcelltraining(dot)net, or call 305-560-5337.
About Global Stem Cells Group:
Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions.
With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.
Global Stem Cells Group’s corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCG’s six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.
Global Stem Cells Group is a publicly traded company operating under the symbol MSSV. https://finance.yahoo.com/quote/mssv/
About Stem Cell Training, Inc.:
Stem Cell Training, Inc. is a multi-disciplinary company offering coursework and training in 35 cities worldwide. Coursework offered focuses on minimally invasive techniques for harvesting stem cells from adipose tissue, bone marrow and platelet-rich plasma. By equipping physicians with these techniques, the goal is to enable them to return to their practices, better able to apply these techniques in patient treatments.
The company’s training courses are designed to make the best use of stem cell technology available to treat various diseases in a manner that is accessible to everyone. Stem Cell Training, Inc.’s mission is to introduce the promising world of cellular medicine to everyone who can benefit from its application, and to provide high quality, effective and efficient training that complies with the highest medical standards to physicians worldwide.
- Published in Press Releases
We may soon be able to heal autoimmune disorders with Stem Cells
Autoimmune disorders are conditions where the body’s immune system mistakenly attacks healthy cells, causing damage to tissues and organs. With over 80 known types, including diabetes type 1, lupus, rheumatoid arthritis, celiac disease, and multiple sclerosis, these disorders affect millions worldwide.
Understanding Autoimmune Disorders
The exact causes of autoimmune disorders remain unclear, though triggers like viruses, bacteria, or certain medications may disrupt immune function, leading the body to attack its own tissues. Common targets include red blood cells, skin, connective tissues, blood vessels, and various glands.
Current Treatments and Limitations
Standard treatments for autoimmune disorders primarily involve immune-suppressing medications, which offer temporary relief but do not provide a cure. Researchers are therefore exploring alternative approaches, such as stem cell therapy, to address these conditions effectively.
The Use of Stem Cells in Autoimmune Disorders
Mesenchymal Stem Cells (MSCs) in Immunomodulation
Research indicates that mesenchymal stem cells, derived from sources like bone marrow, exert immunological functions that help maintain immune balance. Studies, including one published in Arthritis Research and Therapy, highlight MSCs’ ability to regulate immune responses and potentially prevent tissue destruction [1].
Hematopoietic Stem Cells (HSCs) for Severe Autoimmune Diseases
Studies, such as those conducted at Harvard Medical School, explore the use of hematopoietic stem cells in treating severe autoimmune diseases like rheumatoid arthritis and multiple sclerosis. Transplantation of HSCs following immunosuppressive therapies has shown promise in achieving disease remission [2].
Neural Stem Cells (NSCs) in Multiple Sclerosis
In multiple sclerosis research, neural stem cells derived from the central nervous system demonstrate neuroprotective and immunomodulatory effects. Studies suggest these cells could potentially repair damaged nerve tissues and improve symptoms in MS patients [3].
Mesenchymal Stem Cells (MSCs) in Rheumatoid Arthritis
Research on rheumatoid arthritis indicates that mesenchymal cells derived from sources like the placenta possess immunosuppressive properties. Studies, such as those investigating human amnion mesenchymal cells, show promise in alleviating arthritis symptoms and reducing disease severity [4].
Challenges and Future Directions
Despite promising results, challenges remain in optimizing stem cell therapies for autoimmune disorders. Researchers must establish precise protocols and address issues like immune rejection and treatment efficacy in larger clinical settings.
References
- Published in Corporate News / Blog
Adimarket Named Latin American Distributor for Bioquark Biologic Products for the Regeneration and Repair of Human Organs and Tissue with Stem Cells
Adimarket, a Global Stem Cells Group subsidiary, has been named distributor in Latin America for Bioquark Biologic regenerative medicine products, developed for tissue and organ repair and regeneration.
Global Stem Cells Group subsidiary Adimarket has been named the Latin America distributor for Bioquark, Inc.’s biologic products for the regeneration and repair of human organs and tissues. The announcement is the latest in Global Stem Cells Group’s ambitious expansion plans in Latin America, a commitment made to meet the region’s growing demand for access to regenerative medicine and stem cell therapies.
Bioquark Inc. is focused on the development of biologics that have the ability to alter the regulatory state of human tissues and organs, with the goal of curing a range of chronic diseases, as well as affecting complex tissue regeneration. The biologic regulatory states of human cells, tissues and organs represent the central control processes behind disease, degeneration and aging.
Bioquark’s core program focuses on developing a singular class of substances, termed combinatorial biologics, which take a different approach to reversing underlying disease, degeneration or aging processes, as opposed to only effecting only the symptoms of these conditions.
Combinatorial biologics work at the level of the regulatory genome and are modeled off of biochemical dynamics found in various species that can naturally modify biologic regulatory states to achieve beneficial outcomes, such as complex tissue and organ regeneration, disease reversion, and even biological age reversal.
“The revolutionary work that Bioquark is performing is a perfect fit for Global Stem Cells Group’s vision of the potential that stem cell therapies hold, now and in the future,” says Ricardo DeCubas, Global Stem Cells Group co-founder and Cellgenic CEO.
The collaboration between Global Stem Cells Group, Adimarket and Bioquark is another step toward GSCG’s commitment to expanding its presence in communities that need and deserve access to cutting-edge regenerative medicine, not only in Latin America but also worldwide.
For more information visit the Global Stem Cells Group website, email bnovas@stemcellsgroup.com, or call 305-560-5337.
About Global Stem Cells Group:
Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions.
With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine. Global Stem Cells Group’s corporate mission is to make the promise of stem cell medicine a reality for patients around the world. Each of GSCG’s six operating companies focus on a separate research-based mission; the result is a global network of state-of-the-art stem cell treatments and facilities.
Global Stem Cells Group is a publicly traded company operating under the symbol MSSV. https://finance.yahoo.com/quote/mssv/
About Bioquark, Inc.
Founded in 2007, Bioquark, Inc. is a life sciences company developing proprietary combinatorial biologic products for both the regeneration and repair of human organs and tissues. The company’s core program is focused on the development of novel combinatorial biologics capable of directly remodeling diseased, damaged, or aged tissues, and creating micro-environments that induce efficient and controllable regeneration and repair.
Through an innovative approach to biologic regulatory state modification, Bioquark researchers are capable of creating dynamics in mature tissues that are normally only seen during human fetal development, as well as during limb and organ regeneration in organisms like amphibians.
Developed as biologics, Bioquark’s therapeutics will be more amenable to existing regulatory pathways than other cell technologies, and able to circumvent many limitations in the industry’s current offerings.
About Adimarket:
Adimarket, Inc., a division of the Global Stem Cells Group, is a cost-competitive online marketplace for quality regenerative medicine equipment and supplies for physicians and health care professionals.
Adimarket was founded to provide physicians and other health care professionals the tools they need to practice regenerative medicine in a medical office setting. Motivated by a firm belief in the impact the practice of stem cell medicine can have when dispensed in a doctor’s office, Adimarket provides physicians with the tools they need to provide patients with cutting edge treatments.
- Published in Press Releases
Stem Cell Training, Inc. Announces First European Symposium on Cellular and Regenerative Medicine
Global Stem Cells Group and its subsidiary Stem Cell Training announce the company’s first European symposium on cellular and regenerative medicine, to be held in Barcelona, Spain Oct. 9-10, 2015. The symposium will be hosted at the Official Medical College Of Barcelona by J. Victor Garcia Gimenez, M.D., of Therapeutic Confrontations.
Share on TwitterShare on FacebookShare on Google+Share on LinkedInShare on PinterestEmail a friend
stem cell therapies,EuroMedicom,stem cell medicine,global stem cells group,medical tourism,cellgenic,
Stem Cell Training
We have put together a program designed to include cellular communication pathways, influence of the niche in stem cell behavior, and recent studies and supporting investigational protocols for clinical applications.
Miami, FL (PRWEB) May 26, 2015
Global Stem Cells Group and Stem Cell training, Inc. have announced plans for the company’s first cellular and regenerative medicine symposium in Barcelona Spain Oct. 9, 2015, followed by a full day, hands-on stem cell training class Oct. 10. The event will be hosted by J. Victor Garcia Gimenez, M.D., President of Therapeutic Confrontations (CONFTERA) in Barcelona.
In response to the medical community’s increasing interest in regenerative medicine and recent advances in cellular therapies, Global Stem Cells Group, CONFTERA, and their faculties have put together a program designed to include cellular communication pathways, influence of the niche in stem cell behavior, and recent studies and supporting investigational protocols for clinical applications. Theory portions of the symposium will be dictated by relevant members of both faculties.
The symposium will be followed by a full day, hands-on training session on Oct. 10 to provide participating physicians with state-of-the-art techniques for isolating and re-integrating adipose- and bone marrow-derived stem cells, along with clinical protocols.
The symposium will be held in the auditorium of the Official Medical College Of Barcelona.
For more information, visit the Global Stem Cells Group website or the Stem Cell Training, Inc. website, email bnovas(at)stemcellsgroup(dot)com, or call 305-560-5337,
About Global Stem Cells Group:
Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions.
With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.
Global Stem Cells Group’s corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCG’s six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.
Global Stem Cells Group is a publicly traded company operating under the symbol MSSV. https://finance.yahoo.com/quote/mssv/
About Stem Cell Training, Inc.:
Stem Cell Training, Inc. is a multi-disciplinary company offering coursework and training in 35 cities worldwide. Coursework offered focuses on minimally invasive techniques for harvesting stem cells from adipose tissue, bone marrow and platelet-rich plasma. By equipping physicians with these techniques, the goal is to enable them to return to their practices, better able to apply these techniques in patient treatments.
The company’s training courses are designed to make the best use of stem cell technology available to treat various diseases in a manner that is accessible to everyone. Stem Cell Training, Inc.’s mission is to introduce the promising world of cellular medicine to everyone who can benefit from its application, and to provide high quality, effective and efficient training that complies with the highest medical standards to physicians worldwide.
About J. Victor Garcia Gimenez, M.D. and CONFTERA:
J. Victor Garcia Gimenez, M.D., President of Therapeutic Confrontations (CONFTERA), is a specialist in orthopedic surgery and practices cosmetic medicine and surgery, anti-aging medicine, and esthetic therapies in Barcelona.
Garcia Giminez received a Bachelor of Medicine and Surgery degree from the Autonomous University of Barcelona in 1977, and a Specialist in Orthopedic Surgery degree in 1980, also from the Autonomous University of Barcelona. He later received a diploma in Cosmetic Medicine and Surgery from the Autonomous University of Barcelona before attending the National College of Medicine and Aesthetics (Collège National de Médecine et Esthetique) in Montlhéry, France. Garcia Giminiz received a master’s degree in Dermopharmacy and Cosmetology at the University of Barcelona, and a training diploma in Cosmetic Medicine and Surgery at the Medical College of Barcelona; he received a Master’s degree in Cosmetology, Esthetic Medicine and physiological aging from the University of Barcelona.
Garcia Giminiz is the President of the Spanish Society of Medicine and Cosmetic Surgery; Co-director of the UAB-SEMCC; Chairman for Spain of the International Academy of Cosmetic Surgery and a number of additional medical and professional boards.
- Published in Press Releases
STANFORD RESEARCHERS ISOLATE SKELETAL STEM CELLS THAT GIVE RISE TO BONES AND CARTILAGE
Stanford Researchers Isolate Skeletal Stem Cells That Give Rise to Bones and Cartilage
Cartilage and bone deterioration often result from aging, lifestyle factors, or injuries. Unlike bone tissue, mature cartilage has limited self-healing capabilities. Surgical interventions like joint replacement are costly and carry risks such as rejection and infection [1].
Stanford’s Breakthrough in Tissue Engineering
In January 2015, Stanford University School of Medicine scientists made a significant breakthrough in tissue engineering. They successfully isolated skeletal stem cells (myoblasts) capable of generating bone and cartilage in mice. This achievement included mapping the chemical signals crucial for directing stem cell differentiation [2].
Understanding Skeletal Stem Cells
Stem cells are undifferentiated cells with the ability to develop into specialized cell types, replenishing damaged tissues. While embryonic stem cells (ESCs) are pluripotent and controversial due to ethical concerns, adult stem cells from sources like bone marrow and adipose tissue are promising alternatives. Recent research suggests that adult stem cells may differentiate into diverse cell types beyond their tissue of origin.
Stanford’s Research Insights
Stanford’s study focused on rapidly dividing cells found at the ends of mouse bones. Human skeletal muscle-derived cells transplanted into mice showed remarkable regenerative potential after irradiation and cryoinjury preconditioning. This research not only reconstructed bone tissues but also mapped the developmental trajectory of skeletal stem cells.
Irving Weissman, MD, director of the Stanford Institute for Stem Cell Biology and Regenerative Medicine, anticipates these findings will advance human therapies for cartilage and bone regeneration [3].
Differentiation and Therapeutic Applications
Skeletal stem cells contribute to bone formation, adipocyte production (fat cells), and cartilage regeneration. Their potential therapeutic applications extend to treating muscular conditions like muscular dystrophy, joint disorders such as arthritis, and even autoimmune diseases like rheumatoid arthritis and multiple sclerosis.
Challenges and Future Prospects
Despite promising results, challenges in scaling up cell production remain a barrier to widespread clinical application of skeletal stem cell therapies.
References
- Development and Remodeling of Skeletal Tissue – David King, School of Medicine, Southern Illinois University, 2009
- Researchers Isolate Stem Cell That Gives Rise to Bones, Cartilage in Mice – Christopher Vaughan, Stanford Institute for Stem Cell Biology and Regenerative Medicine, 2015
- Stanford Stem Cell Research
- Genetic Control of Skeletal Development
- Published in Corporate News / Blog
PROTEINS PRODUCED BY STEM CELLS, USED IN BONE REGENERATION
Bone loss and weakening are natural effects of aging, beginning as early as age 30. Factors like smoking, inadequate calcium intake, certain medications, and hormonal changes accelerate bone resorption, leading to decreased density, porous bones, and increased fracture risk.
Stem Cell Innovations in Bone Reconstruction
Researchers at the Gladstone Institutes have pioneered a method using proteins derived from stem cells to stimulate bone reconstruction. Unlike traditional methods that rely on bone grafts from cadavers, this approach extracts bone-forming proteins directly from stem cells.
Advantages of Stem Cell Proteins
In experiments on mice, proteins extracted from stem cells were injected into muscle tissue, promoting significant bone growth without the risks associated with traditional bone grafts. This method shows promise for safer, more effective bone repair in humans, with lower rejection and tumor formation risks [1].
Scientific Validation and Clinical Applications
A study published in Scientific Reports affirmed that stem cell-derived proteins offer a reliable source for tissue regeneration. This builds on earlier research, such as Dr. Ranieri Cancedda’s pioneering work using bone marrow cells to repair bone defects [2].
Cutting-Edge Research and Future Directions
Researchers at the National Institutes of Health successfully grew new bone from stem cells derived from skin cells, published in Cell Reports. By reprogramming skin cells into induced pluripotent stem cells (iPSCs) and differentiating them into bone cell precursors, they achieved bone growth in primates without tumor formation. This method harnesses the immune compatibility and versatility of iPSCs, heralding new possibilities for personalized bone regeneration [3].
Conclusion
While the use of stem cells in bone regeneration is advancing, ongoing research aims to refine techniques for optimal integration and long-term effectiveness in human patients.
References
- Published in Corporate News / Blog
Global Stem Cells Group Subsidiary Stem Cell Training Announces Three Stem Cell Training Course Dates in Miami
Global Stem Cells Group and its subsidiary Stem Cell Training, Inc. have announced three upcoming dates for the company’s Adipose and Bone Marrow Stem Cell Training Course for medical professionals in Miami. Courses will be held May 2-3, May 9-10 and June 15-16, 2015.
All three scheduled classes provide the same intensive, hands-on training that covers the latest technology and procedures in adipose and bone marrow stem cell therapy. Practitioners learn skills that can be used to treat patients in their practices, and for career advancement.
Day one of the course will encompass educational lectures on basic stem cells science and the development of adipose stem cells in the treatment of degenerative diseases. Curriculum will include, “Introduction to stem cells II;” “Stem Cell Biology III;” “Embryonic Stem Cells IV;” “Adult Stem Cells V;” “Platelet Rich Plasma VI;” “Adipose Stem Cells and Degenerative Diseases VII;” “Liposuction and Stem Cells VIII;” “Stem Cell (SVF) Isolation Technique IX” and “Regulatory Issues and Standards of Practice.”
Day two will demonstrate live cases to show how the physician performs the procedure in an office setting. Curriculum will include: “Adipose Harvesting Techniques II;” “Stem Cell Isolation Techniques III;” “PRP Processing Demonstration IV;” “Stem Cell Injection Technique V;” “Adipose Harvesting VI;” “Stem Cell Isolation Techniques VII” and “Stem Cell Injection Techniques.”
The May 2-3 course and the June 15-16 course will be held in Miami; the May 9-10 course will be held in Boca Raton and will feature a special guest instructor.
The Adipose and Bone Marrow Stem Cell Training Course was developed for physicians and high-level practitioners to learn techniques in harvesting and reintegrating stem cells derived from adipose tissue and bone marrow. The objective of the training is to bridge the gap between bench science in the laboratory and the doctor’s office by teaching effective, in-office regenerative medicine techniques.
Read More at: Official PR Release
- Published in Press Releases
Global Stem Cells Group to Participate in the IIIº World Congress on Clinical and Esthetic Research in Cordoba, Argentina May 16 and 17, 2015
GlobalStemCellsGroup.com has announced plans to participate in the IIIº World Congress on Clinical and Esthetic Research May 16 and 17, 2015. More than 500 physicians from Argentina, Mexico, Peru, Ecuador, Uruguay, El Salvador, Venezuela, Spain, Chile, Cuba and the U.S. are expected to attend, including specialists in aesthetic medicine, dermatology, plastic surgery, cosmetology, physiotherapy, nutrition and dentistry.
Following the conference, Global Stem Cells Group will conduct an intensive, hands-on course on stem cell harvesting, isolation and re-integration for qualified practitioners.
Hosted by the Association of Clinical and Esthetic Research (ACER), the event’s organizing committee has designed a program highlighting nationally and internationally renowned physicians and esthetic practitioners as featured speakers. The goal is to exchange clinical and scientific findings, and to grow academically.
The event will be held at the Hotel Amerian in the City of Villa Carlos Paz, Córdoba.
For more information visit the IIIº World Congress on Clinical and Esthetic Research website.
Read More at: Official PR Release
- Published in Press Releases
Global Stem Cells Group to Host Featured Speaker at The Aesthetic Meeting 2015 in Montreal
Global Stem Cells Group Advisory Board member Alfredo Hoyos, M.D., will be a featured speaker at The Aesthetic Meeting May 14-19, 2015. Hoyos will promote the company’s new stem cell assisted fat transfer training course for medical professionals.
Global Stem Cells Group today announced plans to attend The Aesthetic Meeting 2015, an annual gathering of aesthetic medicine experts and innovators. GSCG Advisory Board member Alfredo Hoyos, M.D., is scheduled to introduce the company’s brand new training course that combines facial fat transfer injection techniques with adipose-derived stem cell techniques.
The course is designed to address the primary issues that concern patients in the aesthetic field, including facial aging caused by volume loss.
The Aesthetic Meeting is one of the aesthetic surgery industry’s biggest annual events, attracting leading educators, researchers and practitioners from around the world to discuss evidence-based medicine in aesthetic plastic surgery. According to organizers, it is an opportunity to meet with physicians who specialize in aesthetic plastic surgery of the face and body, and learn what advances are being made in the aesthetics field. This year’s meeting will also focus on what to expect beyond 2015 in the world of aesthetic and anti-aging medicine.
Dedicated exclusively to aesthetic surgery and cosmetic medicine education, The Aesthetic Meeting will offer attendees an array of new techniques, key research findings, and helpful information that physicians can apply in their own practice. The Aesthetic Meeting 2015 features a number of special presentations, panels and papers by surgeons with vast experience in aesthetic surgery. Additionally, you’ll gain valuable insights and pearls of wisdom from our international colleagues, as they often have the opportunity to implement new therapies, devices and techniques before they reach the U.S.
The Aesthetic Meeting 2015 will be held at the Palais des Congrès de Montréal in Montréal, from May 14 – 19, 2015. For more information, visit the The Aesthetic Meeting website, visit the Global Stem Cells Group website, email bnovas(at)stemcellsgroup(dot)com, or call 305.224.1858.
Read More at: Official PR Release
- Published in Press Releases
